
Eledon Pharmaceuticals: Sharing Innovations at the Guggenheim Securities SMID Cap Biotech Conference
Eledon Pharmaceuticals: A New Breakthrough in Cancer Treatment IRVINE, Calif., Jan. 29, 2025 – Eledon Pharmaceuticals, Inc. (Nasdaq: ELDN), a leading biopharmaceutical company, recently made headlines with an exciting announcement regarding their latest cancer treatment discovery. The company’s CEO, David-Alexandre C., shared details about this groundbreaking development during a press conference. The Discovery David-Alexandre C….